MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$43,774
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
0 0* 0 0
Selling, general and administrative
60,271 -85,691 115,099 13,614
Total operating expenses
60,271 -85,691* 115,099 13,614
Gain from operations
-60,271 85,691* -115,099 -13,614
Liability forgiveness
-15,386.5* --
Liability extinguishment
20,000 ---
Interest expense - related parties
3,503 2,167* 2,710 1,948
Total other expenses
--2,710 1,948
Total other income (expense)
16,497 13,219.5* --
Gain before income tax expense
-98,910.5* -117,809 -15,562
Income tax expense
-0* 0 0
Net gain
-43,774 98,910.5 -117,809 -15,562
Diluted EPS
0 0.002 0 0
Diluted Average Shares
60,042,000 60,042,000 60,042,000 60,042,000
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Liability extinguishment$20,000 Net gain-$43,774 Total other income(expense)$16,497 Interest expense -related parties$3,503 Gain from operations-$60,271 Total operatingexpenses$60,271 Selling, general andadministrative$60,271

ACRO BIOMEDICAL CO., LTD. (ACBM)

ACRO BIOMEDICAL CO., LTD. (ACBM)